Furthermore, in patients with normocalcaemic persistent secondary hyperparathyroidism after kidney transplantation, cinacalcet improved the control of serum PTH without causing calcaemia, or phosphataemia. This evidence concerns the gene PTH and secondary hyperparathyroidism.